• In Q2-FY2022 (quarter ended December 2021), this company reported $3.2M in revenue, up 106% YoY and 73% QoQ, beating our expectations due to faster than expected roll out of its 2.0 products.
            • This report is currently available to premium subscribers – Free subscribers will gain access on March 9th, 2022
              Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay

Visit Ayurcann Holdings Corp. page for more research, discussion boards and to like, and share.

Download Analyst Report :

Investors are also interested in: